The association of NAD(P)H oxidase p22phox with diabetic nephropathy is still uncertain [5] (multiple letters)

Diabetes Care

Volumn 27, Issue 6, 2004, Pages 1518-1519

  Doi, Kent ^a   Noiri, Eisei ^a   Tokunaga, Katsushi ^a   Hodgkinson, Andrea D ^b   Millward, Beverley A ^b   Demaine, Andrew G ^b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

^c ITTC Building ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P22PHOX; UNCLASSIFIED DRUG;

ALLELE; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHY; DIABETIC NEPHROPATHY; DISEASE DURATION; ERROR; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HETEROZYGOTE; HUMAN; LETTER; MAXIMUM LIKELIHOOD METHOD; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL ANALYSIS;

CASE-CONTROL STUDIES; DIABETIC NEPHROPATHIES; HUMANS; MEMBRANE TRANSPORT PROTEINS; NADPH DEHYDROGENASE; NADPH OXIDASE; PHOSPHOPROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 2542500078     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.6.1518     Document Type: Letter

References (0)